Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z8NC
|
||||
Former ID |
DNC007128
|
||||
Drug Name |
LUF-5981
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540975] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H23N3
|
||||
InChI |
InChI=1S/C24H23N3/c1-4-10-17(11-5-1)20-16-21(18-12-6-2-7-13-18)25-24-22(20)26-23(27-24)19-14-8-3-9-15-19/h1-2,4-7,10-13,16,19H,3,8-9,14-15H2,(H,25,26,27)
|
||||
InChIKey |
DXBBMCIVYYJMJC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [528673] | |
Adenosine A2a receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [528673] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.